Hi Badger,
sorry for the delay answering.
I designed the two CRISPRs (in the pX330) targeting the region near the ATG and the STOP codon with the original idea to put an N-term or C-term tag because for my GOI I do not have a nice antibody. Although the T7 was very nice for both, I did not have luck with the repair using ssODN and I decided to use the 2 CRISPR at the same time in co-transfection to remove the entire locus (without any template repair plasmid/oligos).
I genotyped at the beginning the pool of transfected cells. I observed a decreased intensity of both PCRs at the 5'UTR and 3'UTR compared to the wilde-type cells. More important, I saw a PCR product product (of about 470bp) spanning the 70Kb region using the forward on the 5'UTR and reverse on the 3'UTR only in the CRISPRs transfected pool and not in the parental cells (see pdf). Encouraged, I screened many clones (about 100 total) obtained by single cells sorting, looking for clones that have the hybrid PCR product but not the PCR at the 5'UTR neither at the 3'UTR (some clones still have one of the two…).
Finally, I sequenced the hybrid PCR to confirm that corresponded to the 5'UTR "ligated" to the 3'UTR) and I re-confirmed the result by qPCR.
The efficiency was better in K562 (20% - 8/40 clones total) and THP-1 (17% - 2/12 clones total) compared to HeLa (3% - 3/96 clones total).
Best,
Andrea